FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology and represents a Fc-containing polypeptide containing amino acid sequence SEQ ID NO: 18, where SEQ ID NO: 18 comprises mutations at amino acid positions 243 and 264 of Fc region, where Fc-containing polypeptide represents an antibody or antibody fragment containing sialylated N-glycans, and where mutation in position 243 represents F243A and mutation in position 264 represents V264A, where numbering is made according to EU index as in Kabat, where Fc-containing polypeptide has low binding with FcγRI, FcγRIIa, FcγRIIb and/or FcγRIIIa compared to parent Fc-containing polypeptide. Invention also relates to a method of producing said Fc-containing polypeptide in a host cell, as well as to a method of treating an inflammatory condition in an individual in need thereof, involving administering a therapeutically effective amount of said Fc-containing polypeptide.
EFFECT: invention enables to obtain Fc-containing polypeptide having reduced binding with FcγRI, FcγRIIa, FcγRIIb and/or FcγRIIIa compared with parent Fc-containing polypeptide.
13 cl, 22 dwg, 14 tbl, 24 ex
Title | Year | Author | Number |
---|---|---|---|
SITE-SPECIFIC ANTIBODY-DRUG CONJUGATION BY MEANS OF GLYCOENGINEERING | 2014 |
|
RU2711935C2 |
HYPERGLYCOSYLATED BINDING POLYPEPTIDES | 2014 |
|
RU2708314C2 |
PRODUCTION OF GLYCOPROTEINS WITH MODIFIED FUCOSYLATION | 2008 |
|
RU2479629C2 |
HEMAGGLUTININ POLYPEPTIDES, AND REAGENTS AND METHODS RELATING THERETO | 2011 |
|
RU2663718C2 |
ANTIBODY AGAINST MUC1 | 2019 |
|
RU2792347C2 |
POLYPEPTIDE EXPRESSION VECTOR WITH SYALIDASE ACTIVITY, METHOD FOR PROVIDING SYALIDASE ACTIVITY IN CELL CULTURE AND METHOD FOR CONTROLLING PROPERTIES OF Fc-CONTAINING MOLECULES EXPRESSED IN CELL LINE | 2007 |
|
RU2466189C2 |
RECOMBINANT GLYCOPROTEINS WITH SIALYLATED O-GLYCANS AND CELL LINES FOR THEIR PRODUCTS | 2015 |
|
RU2714209C2 |
METHODS RELATING TO MODIFIED GLYCANS | 2009 |
|
RU2526250C2 |
METHODS FOR PRODUCING RECOMBINANT GLYCOPROTEINS WITH MODIFIED GLYCOSYLATION | 2015 |
|
RU2704830C2 |
FUSED POLYPEPTIDE WITH ANTICANCER ACTIVITY | 2016 |
|
RU2727165C2 |
Authors
Dates
2016-12-10—Published
2011-05-25—Filed